Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
03/2006
03/28/2006US7018797 Method for treating neurodegenerative disorders
03/28/2006CA2153805C C10 taxane derivatives and pharmaceutical compositions
03/28/2006CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006032023A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
03/23/2006WO2006031969A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
03/23/2006WO2006029532A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006US20060063949 Medicinal disulfide salts
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006CA2580627A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006CA2580534A1 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives and use thereof as ppar modulators
03/23/2006CA2580491A1 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives and use thereof as ppar modulators
03/22/2006EP1635800A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
03/22/2006CN1751037A Sulfonamide derivatives as PPAR modulators
03/22/2006CN1246300C Resorcinol derivatives
03/22/2006CN1246295C Method and intermediate used for manufacturing antifolic
03/21/2006US7015347 Stable no-delivering compounds
03/21/2006US7015208 carbocyclic alcohols such as 5-Chloro-2-methylsulfonylindan-1-ol and isomers, used as anorexigenic agents; side effect reduction; nontoxic
03/21/2006CA2244140C Alkylated styrenes as prodrugs to cox-2 inhibitors
03/21/2006CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
03/21/2006CA2181366C Hydrogenation catalyst, process for the preparation thereof and hydrogenation process
03/21/2006CA2135535C Medicinal formulations containing thioctic acid or dihydrolipoic acid in the form of inclusion compounds with cyclodextrins or cyclodextrin derivatives and in the form of granulates, chewable or effervescent tablets
03/21/2006CA2072416C Cyclopropenone derivatives
03/16/2006WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13
03/16/2006US20060058393 Peroxisome proliferator activated receptor moderators; dyslipidemia; anticholesterol agents ; antidiabetic agents; hypotensive agents; antiischemic agents
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/16/2006DE102004038146A1 Verfahren zur Spaltung von Thiazolidinen A process for cleavage of thiazolidines
03/16/2006CA2579004A1 Mercaptoamides as histone deacetylase inhibitors
03/15/2006EP1635220A2 Oxime derivatives and the use thereof as photoinitiators
03/15/2006EP1634957A1 2-alkylcysteinamide or salt thereof, process for producing these, and use of these
03/15/2006EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes
03/15/2006EP1633705A1 Oxidation of mercaptoethanol
03/15/2006EP1633704A2 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
03/15/2006EP1175388B1 Spect imaging agents for serotonin transporters
03/15/2006EP0997147B1 Amino acid derivatives
03/15/2006CN1747928A Acylated aminopropanediols and analogues and therapeutic uses thereof
03/15/2006CN1746155A Preparation of trifluo-thioanisole
03/15/2006CN1245380C Anthranilic acid derivatives
03/15/2006CN1245157C Novel fatty derivative for treatment of diabetes
03/14/2006US7012161 Compound, fluorine-containing polymerizable cyclic olefin compound
03/14/2006US7012159 Phenolic compounds and recording materials containing the same
03/14/2006US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
03/14/2006US7011960 Substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acids
03/14/2006US7011838 Malononitrile compounds and their use as pesticides
03/14/2006CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors
03/14/2006CA2268796C Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
03/14/2006CA2256396C Process for producing optically active amines
03/14/2006CA2147984C Butenyl-substituted taxanes and composition
03/14/2006CA2125223C Control of scale formation and corrosion in aqueous systems
03/14/2006CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
03/09/2006WO2006024412A2 Optically active phthalamides
03/09/2006WO2006024402A1 Chiral 3-halophthalic acid derivatives
03/09/2006WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
03/09/2006WO2005060692A3 Biphenyl compounds and methods
03/09/2006US20060052627 Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
03/09/2006US20060052614 Such as 5-amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)pyrazole by reacting hydrazine and dicyanoacetylene in chloroform, stirring, heating, the crystallizing in hexane/toluene solvent; for preparation of pesicidal intermediates
03/09/2006US20060052600 Amino-functional chalcones
03/09/2006US20060052449 4'-(2-phenoxy-ethylsulfanylmethyl)-biphenyl-3-carboxylic acid (3-dimethylamino-propyl)-amide oxalate; inhibiting release of the melanin concentrating hormone; treating Type II Diabetes, obesity
03/09/2006US20060051846 Process for producing l-alpha-methylcysteine derivative
03/09/2006CA2577942A1 Chiral 3-halophthalic acid derivatives
03/08/2006EP1632496A1 Reagents and methods for solid phase synthesis and display
03/08/2006EP1632470A2 Calcium receptor active molecules
03/08/2006EP1631586A2 Peptide analogues comprising at least one type of aminoacyl aza-beta 3 and the use thereof, in particular for therapy
03/08/2006EP1631147A2 Alkoxy alkylsulfanyl phenols
03/08/2006EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
03/08/2006EP1198454B1 Mutilin derivatives and their use as antibacterials
03/08/2006EP1102776B1 Water soluble prodrugs of hindered phenols
03/08/2006EP1039902B1 Inhibitors of gap junction communication
03/08/2006EP0891330B1 Substituted phenyl keto enols as pesticides and herbicides
03/08/2006CN1743309A Synthesis of optical active cyanhydrin compound by enzyme chemical process
03/08/2006CN1244569C C-10 position taxane derivative and its medicine composition
03/08/2006CN1244542C Aromatic amine derivatives having NOS inhibitory effect
03/08/2006CN1244532C Process for preparing intermediates
03/08/2006CN1244323C Novel fatty acid analogues for the treatment of primary and secondary restenosis
03/07/2006US7008919 For use in cologne, a soap, a shower or bath gel, a shampoo or hair-care product, a cosmetics, a body or ambient air deodorant, a detergent or a fabric softener, or a household product; dessert, ice-cream, candy, beverage, fruit jam
03/02/2006WO2006022237A1 Medicament for preventing or treating fatty liver
03/02/2006DE102004041250A1 Herstellung von 2-Hydroxy-4-Methylthiobuttersäure Preparation of 2-hydroxy-4-methylthiobutyric acid
03/02/2006CA2576325A1 Optically active phthalamide derivative, agricultural or horticultural insecticide, and method of using the same
03/01/2006EP1628952A1 Ionic liquid comprising uronium cations or thiouronium cations
03/01/2006CN1741992A 大麻素受体配体 Cannabinoid receptor ligands
03/01/2006CN1741984A CaSR antagonist
03/01/2006CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
02/2006
02/28/2006US7006344 Capacitor comprising bis(4-mercaptophenyl) sulfide derivative
02/28/2006US7005071 Method of generating metal chelating affinity ligands
02/28/2006CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/23/2006WO2006019149A1 Method for producing 2-hydroxy-4-methylthiobutanoic acid
02/23/2006WO2005080324A8 Sulfonamide derivatives for the treatment of diseases
02/23/2006US20060041045 Graftable 4-amino-3-sulfinyl-substituted diphenylamine stabilizers for vulcanizates
02/23/2006US20060041024 Polycationic compounds and uses thereof
02/23/2006US20060040979 3-Aryl-2-hydroxypropionic acid derivative I
02/23/2006US20060040869 Pharmaceutically useful compounds
02/23/2006DE102004039486A1 Production of organic compounds of trace elements, e.g. zinc methionate for use as animal feed additive, involves the solid-state reaction of a metal oxide and a solid organic acid in a pulveriser, e.g. a vibration grinding mill
02/23/2006CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
02/22/2006EP1627867A1 (meth)acrylic ester compound and use thereof
02/22/2006EP1627683A2 Metal chelating compositions
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 272